Notizie e Video - GlobeNewsWire

SHANGHAI, China, May 22, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS”, “GDSH” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Net revenue increased by 9.1% year-over-year (“Y-o-Y”) to RMB2,627.4 million (US$363.9 million) in the...

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Warpaint London PLC (LSE: W7L; OTCQX: WPNTF), a branded cosmetics company, has qualified to trade on the OTCQX ® Best Market. Warpaint London PLC upgraded to OTCQX from the Pink ® market. Warpaint London PLC begins trading today on OTCQX under the symbol “WPNTF.” U.S. investors can find current financial...

ROAD TOWN, British Virgin Islands, May 22, 2024 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“ Aura ” or the “ Company ”) is pleased to announce that it recently acquired, through its subsidiary Aura Matupá, the right to explore the Pé Quente and Pezão Projects (the “ Projects ”) in the State of Mato Grosso, Brazil (the “ Acquisition ”). The Projects consist of a total of 6 Mineral Rights and are located in the geological setting of Alta...

Press Release Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy Acquisition strengthens Nokia’s tactical communications portfolio offer 22 May 2024 Espoo, Finland – Nokia today announced the successful completion of its acquisition of Fenix Group, a privately held company that specializes in tactical communications solutions for the defense communities. The acquisition, originally announced in December 2023, strengthens Nokia's position in the defense sector...

Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A Resistance-Associated Substitutions (RAS) Detected in HCV-infected Patients BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral...

BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” or the “Company”), a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it will present at the 2024 BIO International Convention which will be held June 3-6, 2024, in San Diego, California. Event: BIO International Convention Date: June...

TORONTO, May 22, 2024 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX:WDO, OTCQX:WDOFF) (“Wesdome” or the “Company”) today announces the appointment of Kevin Lonergan as Senior Vice President, Technical Services effective May 21, 2024. Anthea Bath, President and CEO, commented: “On behalf of the board, I am pleased to welcome Kevin to our senior leadership team. Kevin has extensive experience in the global mining sector having worked at all levels from core operations to senior...

Charlotte, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, has announced the final release to manufacturing of design updates across its product portfolio. Akoustis developed the updates to its XBAW ® manufacturing process to remove any patented features claimed by Qorvo, Inc. in...

TORONTO and HOUSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it will present an update on the MDNA11 ABILITY-1 Trial at the Sachs 10 th Annual Oncology Innovation Forum . The forum takes place on Friday, May 31 st , 2024, as part of the clinical partnering and investment activities surrounding the 2024...

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that two new independent directors, Dr. Srishti Gupta and Kevin F. McLaughlin, were elected to its Board of Directors at the annual meeting of stockholders on May 21, 2024. Dr. Gupta will serve as the Chairperson of the Compensation Committee and Mr. McLaughlin will serve as the Chairperson of the Audit...

Combines Achilles’ best-in-class AI-driven, tumor-targeting technology with Arcturus’ world-leading self-amplifying mRNA platform Combined technologies have the potential to generate potent and durable T cell responses in pre-clinical IND-enabling studies LONDON, May 22, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced a research collaboration...

GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Regenerative Medicine Advanced Therapy (“RMAT”) designation for Descartes-08 for the treatment of myasthenia gravis (“MG”). Descartes-08, the Company’s lead product candidate, is an autologous mRNA...

1Q24 Revenue of $68.6 million at the high end of the guidance range. 1Q24 Non-GAAP Operating Income of $4.4 million or 6% compared to a loss of ($8.8) million or (13%) in 1Q23. Record high Free Cash Flow of $16.6 million and 24% margin compared to cash burn of ($8.3) million and (13%) in 1Q23. Introducing WalkMe X , the industry’s first always on, contextual AI copilot that proactively delivers next best actions to users across any workflow or application. SAN FRANCISCO, May 22, 2024 (GLOBE...

CHICAGO, May 22, 2024 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) today announced that the company will be presenting at the following investor conferences: On Wednesday, May 29, 2024, Chris Cartwright, President and CEO, will present at the Bernstein Strategic Decisions Conference. The presentation is scheduled to begin at 9:00 a.m. CT (10:00 a.m. ET). On Tuesday, June 4, 2024, Todd Cello, Executive Vice President, Chief Financial Officer, will present at the Baird Global Consumer, Technology...

DUBLIN and SHANGHAI, May 22, 2024 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Total revenues in the quarter were RMB86,812.1 million (US$ 1 12,023.3 million), an increase of 131% from RMB37,637.1 million in the same quarter of 2023. Operating profit in the quarter was RMB25,973.7 million (US$3,597.3 million), an increase of...

RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures, announced a global licensing agreement (excluding the Asia-Pacific region) for lerociclib for radioprotective uses. Lerociclib is a potent and selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). Such inhibitors can increase the survival of animals exposed to...

CHANTILLY, Va., May 22, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was one of 15 lead consultants selected by Los Angeles World Airports (LAWA) for a Multiple Award Task Order Contract (MATOC) to perform on-call, task order-based, professional services for LAWA’s Capital Improvement Program. The Program Services MATOC represents nearly $1 billion in contracting value over a term of five years and will serve both Los Angeles International Airport...

TORONTO, May 22, 2024 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX: WM, OTCQB:WLBMF) (“ Wallbridge ” or the “ Company ”) is pleased to announce that it has received final assay results from its 2,396 metre drilling program completed in March 2024 at its 100% owned Fenelon Gold Project (“ Fenelon ”). Highlights Intersected multiple high-grade gold-bearing structures in the Enterprise and Andromeda vein swarms of the Area 51 zone at depths ranging between 60 and 150...

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Rathbones Group Plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in...

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Rathbones Group Plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in...